3902 participants
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-12-18
- Completion:
- 2033-11-30
Conditions
- Breast Cancer
Interventions
- DRUG
- OTHER
No Results Yet